secondary myelofibrosis

Showing 1 - 25 of 28

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 10, 2023

Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,

Active, not recruiting
  • Acute Leukemia
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 18, 2022

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, radiation)

Recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 21, 2022

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Greifswald, Halle (Saale) (Fedratinib Oral Capsule [Inrebic], Nivolumab)

Recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Greifswald, Germany
  • +1 more
Jun 15, 2022

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston

Completed
  • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 27, 2022

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 7, 2022

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Duarte (procedure, drug, other)

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Duarte, California
    City of Hope Medical Center
Nov 2, 2021

Primary Myelofibrosis, Secondary Myelofibrosis, PMF Trial in Germany (INCB018424/CC-4047)

Active, not recruiting
  • Primary Myelofibrosis
  • +5 more
  • Aachen, Germany
  • +16 more
Sep 28, 2021

Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies Trial in Rochester (Imetelstat)

Completed
  • Primary Myelofibrosis
  • +2 more
  • Rochester, Minnesota
    (unnamed)
Aug 24, 2021

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)

Completed
  • Brain and Central Nervous System Tumors
  • +10 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Sep 3, 2021

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston (drug, biological, procedure, radiation)

Completed
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2020

Chronic Myeloproliferative Disorders, Secondary Myelofibrosis Trial in Rochester (CC-4047)

Completed
  • Chronic Myeloproliferative Disorders
  • Secondary Myelofibrosis
  • Rochester, Minnesota
    Mayo Clinic
Dec 16, 2019

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (Platelet Transfusion)

Terminated
  • Acute Biphenotypic Leukemia
  • +13 more
  • Platelet Transfusion
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2019

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +77 more
  • fludarabine phosphate
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 16, 2019

GVHD, Leukemia, Lymphoma Trial (biological, drug, genetic, other, procedure)

Completed
  • Graft Versus Host Disease
  • +6 more
  • anti-thymocyte globulin
  • +13 more
  • (no location specified)
Mar 5, 2018

GVHD, Leukemia, Lymphoma Trial in Minneapolis (drug, procedure, radiation)

Terminated
  • Graft Versus Host Disease
  • +5 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 29, 2017

Anemia, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale, New York (ruxolitinib phosphate, danazol,

Completed
  • Anemia
  • +2 more
  • ruxolitinib phosphate
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Sep 15, 2017

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Cleveland (peripheral blood lymphocyte therapy, allogeneic

Terminated
  • Chronic Myeloproliferative Disorders
  • +6 more
  • peripheral blood lymphocyte therapy
  • +3 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Center
Apr 18, 2017

Acute Myeloid Leukemia in Remission, Primary Myelofibrosis, Primary Myelofibrosis, Prefibrotic Stage Trial in Duarte (procedure,

Withdrawn
  • Acute Myeloid Leukemia in Remission
  • +4 more
  • Allogeneic Bone Marrow Transplantation
  • +9 more
  • Duarte, California
    City of Hope Medical Center
Sep 12, 2016

Reversible Secondary Myelofibrosis or Clonal Myeloproliferative

Terminated
  • Primary Myelofibrosis
  • +3 more
    • Salt Lake City, Utah
    • +1 more
    Mar 17, 2016

    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Detroit (drug, procedure, radiation)

    No longer available
    • Leukemia
    • +5 more
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Feb 26, 2016

    Chronic Myeloproliferative Disorders, Secondary Myelofibrosis Trial in Rochester (Dacogen)

    Terminated
    • Chronic Myeloproliferative Disorders
    • Secondary Myelofibrosis
    • Rochester, Minnesota
      Mayo Clinic
    Nov 25, 2015

    Chronic Myeloproliferative Disorders, GVHD, Infection Trial in Phoenix, Duarte (biological, drug, procedure, radiation)

    Completed
    • Chronic Myeloproliferative Disorders
    • +10 more
    • anti-thymocyte globulin
    • +12 more
    • Phoenix, Arizona
    • +1 more
    Sep 3, 2014